Evidence map›Paper›PMID 34287265›Full record

ReviewCurrent oncology (Toronto, Ont.)2021

The Role of PET in Supratentorial and Infratentorial Pediatric Brain Tumors.

Angelina Cistaro, Domenico Albano, Pierpaolo Alongi, Riccardo Laudicella, Daniele Antonio Pizzuto, Giuseppe Formica, Cinzia Romagnolo, Federica Stracuzzi, Viviana Frantellizzi, Arnoldo Piccardo and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Current oncology (Toronto, Ont.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 2 countries.

Angelina CistaroNuclear Medicine Department, Ospedali Galliera, 16128 Genova, Italy.ORCID 0000-0001-8024-8425
Domenico AlbanoDepartment of Nuclear Medicine, University of Brescia and Spedali Civili Brescia, 25123 Brescia, Italy.ORCID 0000-0003-0810-6494
Pierpaolo AlongiUnit of Nuclear Medicine, Fondazione Istituto G. Giglio, 90015 Cefalù, Italy.ORCID 0000-0002-8397-1640
Riccardo LaudicellaNuclear Medicine Unit, Department of Biomedical and Dental Sciences and of Morpho-Functional Imaging, A.O.U. Policlinico G. Martino, University of Messina, 98125 Messina, Italy.ORCID 0000-0002-2842-0301
Daniele Antonio PizzutoDepartment of Nuclear Medicine, University Hospital Zürich, 8091 Zürich, Switzerland.ORCID 0000-0003-1176-9184
Giuseppe FormicaNuclear Medicine Unit, Department of Biomedical and Dental Sciences and of Morpho-Functional Imaging, A.O.U. Policlinico G. Martino, University of Messina, 98125 Messina, Italy.
Cinzia RomagnoloNuclear Medicine Unit, Ospedali Riuniti, Torrette di Ancona, 60126 Ancona, Italy.
Federica StracuzziNuclear Medicine Unit, Department of Biomedical and Dental Sciences and of Morpho-Functional Imaging, A.O.U. Policlinico G. Martino, University of Messina, 98125 Messina, Italy.
Viviana FrantellizziDepartment of Radiological Sciences, Oncology and Anatomical Pathology, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0003-3497-4236
Arnoldo PiccardoNuclear Medicine Department, Ospedali Galliera, 16128 Genova, Italy.ORCID 0000-0002-6779-1471
Natale QuartuccioAIMN Pediatric Study Group, 20159 Milan, Italy.ORCID 0000-0001-9845-1384
University of Messina · ITEnte Ospedaliero Ospedali Galliera · ITAzienda di Rilievo Nazionale ed Alta Specializzazione · ITFondazione Istituto G. Giglio di Cefalù · ITOspedali Riuniti di Ancona · ITSapienza University of Rome · ITUniversity Hospital of Zurich · CHUniversity of Brescia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis review aims to provide a summary of the clinical indications and limitations of PET imaging with different radiotracers, including 18F-fluorodeoxyglucose (18F-FDG) and other radiopharmaceuticals, in pediatric neuro-oncology, discussing both supratentorial and infratentorial tumors, based on recent literature (from 2010 to present).

methodsA literature search of the PubMed/MEDLINE database was carried out searching for articles on the use of PET in pediatric brain tumors. The search was updated until December 2020 and limited to original studies published in English after 1 January 2010.

results18F-FDG PET continues to be successfully employed in different settings in pediatric neuro-oncology, including diagnosis, grading and delineation of the target for stereotactic biopsy, estimation of prognosis, evaluation of recurrence, treatment planning and assessment of treatment response. Nevertheless, non-18F-FDG tracers, especially amino acid analogues seem to show a better performance in each clinical setting.

conclusionsPET imaging adds important information in the diagnostic work-up of pediatric brain tumors. International or national multicentric studies are encouraged in order to collect larger amount of data.

Indexed as

Brain NeoplasmsNeoplasm Recurrence, LocalChildFluorodeoxyglucose F18HumansPositron-Emission TomographyRadiopharmaceuticalsFluorodeoxyglucose F18Radiopharmaceuticalsbrain tumorspediatricspositron emission tomography

Identifiers

PMID34287265
PMCPMC8293135
OpenAlexW3182737554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.